Stop To Smell The ‘Lavender’: Being Pain-Free


Therapeutic Grade Lavender Essential Oil Proves More Effective Than Drugs In Treating Migraines (1)

Since real cures for migraines have not been found yet, migraineurs often make do with taking drugs on a long-term basis that tackle some but not all of the symptoms associated with a migraine episode. So the injections, patches, magnetic stimulators, pills, nasal delivery techniques address pain mitigation or at most one other symptom migraineurs experience during their intense episodes. As migraineurs are usually in for the long haul, their drug intake is also long term as is their experience with unnecessary medication side effects and that is why a lot of us start to explore natural options.

Lavender has long been used in the management of anxiety in natural, holistic and traditional medicines. For the first the first time the effect of therapeutic grade lavender oil was studied in the treatment of migraine pains. The study conducted by the Department of Neurology, School of Medicine, Mashad University of Medical Sciences, Mashad, Iran. The report of the study was published in the online version of PubMed’s April 2012 issue. Abstract of the research details may be accessed (2)

A total of 47 participants who had been clinically diagnosed with migraine were studied. They were divided in two groups randomly – the case group and the control group.

The case group was instructed to apply 2-3 drops of therapeutic grade essential oil on their upper lip at the onset of migraine pain. They were to inhale the emanating vapours for 15 minutes and grade the severity of their migraine pain at intervals of 30 minutes for the next 2 hours.

The control group was given the very same instructions except that they were provided scented paraffin to apply to their upper lips for inhalation of vapours. Neither of the groups knew what they were being given in the unlabelled bottles.

The lavender group not only reported a 71% improvement in the severity of their symptoms, they also reported significantly fewer migraines than the placebo group. In other words, lavender helped migraine sufferers about three quarters of the time. (3)

Compared to the efficacy rates of high dose Tylenol at 50%, 57% for Ibuprofen and 59% for Imitrex, lavender oil scores beautifully over pharmaceutical drugs and comes with negligible side-effects if any at all compared to the drugs.

Lavender headache pillows stuffed with dried lavender petals and buds, lavender puches that may be embedded into scarves or tied to handkerchiefs may also be used to manage migraines. Other versatile ways of using lavender to counter migraines may be learnt at the Lavender Bee Farm website. (4)


  1. Image Credit: Lavender Bee Stock Photo; “Lavender Bee” by Simon Howden; Free Digital Photos; Web January 2014;
  2. RESEARCH ABSTRACT: Lavender essential oil in the treatment of migraine headache: a placebo-controlled clinical trial; NBI Resources – Pub Med; Web January 2014;
  3. Essential Lavender Oil: A Natural Solution for Migraines and Anxiety; Conscious Life News; Web January 2014;
  4. Lavender Therapy for Migraine Headaches; Lavender Bee FARM; Web Jaunuary 2014;

FOR VIDEO: Lavender for Migraine Headaches; Nutrition Facts; Web January 2014;

Copyrights apply to this blog. Please refer copyright permissions.

Health Canada Recalls GSK’s Imitrex

Imitrex syringe

Potentially Infected Needles In Injection Form Of Imitrex (1)

Pharmaceutical giant GlaxoSmithKline (GSK) has recalled lot number C637078 and C632842 of it’s migraine drug Imitrex. The recalled drug is not of the tablet or nasal spray form but it’s injection form which comes in syringes pre-filled with the sumatriptan solution along with sterile needles that are to be injected.

The decision to recall has been made in discussions with Health Canada. Health Canada is Canada’s federal department that helps its citizens maintain, regulate and improve their health.

Fears have been allayed with clarifications from the regulatory body that it is not the quality of the drug that was suspect but that the needles were protruding past their plastic shields thus compromising their sterility thus posing potential risk of infection to consumers. (2)


  1. Image Credit: Health Warehouse; Disposable Syringes 5/8” Needle; Web November 2013;
  2. Migraine medication Imitrex recalled by Health Canada; CBC News, Calgary; Web November 2013;

Copyrights apply to this blog. Please refer copyright permissions. 

OptiNose – New Migraine Treatment: Data Presented At IHC 2013

TE_optinoseOptiNose’s Breath Powered Nasal Delivery Device (1)

Drug delivery technology corporation OptiNose Inc. has presented results of a pivotal phase III TARGET study at the International Headache Congress at Boston comparing both the efficacy and the safety of it’s newly developed technology – the OptiNose Breath Powered nasal delivery device with other drug delivery systems and placebos. The abstracts are to be published in Cephalalgia, the Journal of the International Headache Society

The breath-powered device containing low dose sumatriptan was used to deliver the drug in patients experiencing moderate to severe migraine pain, and then compared to placebo administered via the same route later.

According to Ramy A. Mahmoud, M.D., M.P.H., Chief Operating Officer of OptiNose, “Various data we are presenting today will highlight how this novel delivery technology improves the delivery of medicine to hard-to-reach regions deep in the nasal cavity, how it can produce fast and efficient absorption of medicine into the blood, and how effective treatment with this technology can be. There are nearly 30 million migraine sufferers in the United States and many will be able to benefit from a new low-dose treatment that can rapidly provide effective pain relief with few adverse events.” (2)

Sections discussed in the International Headache Congress 2013 included:

  • Efficacy and Safety of a Novel Breath Powered Powder Sumatriptan Intranasal Treatment for Acute Migraine;
  • Data from a randomized, single-dose, four-way cross-over study assessing the absorption into the blood of sumatriptan intranasal powder administered using the  Breath Powered OptiNose drug delivery device compared to Imitrex® subcutaneous injection, Imitrex nasal spray and Imitrex oral tablets in healthy adult volunteers.
  • A review of evidence for human in vivo drug deposition patterns in different regions of the nose with devices intended to provide reliable and efficient drug delivery to upper/posterior nerve structures deep in the nasal cavity.

To know more about the TARGET study, please visit the OptiNose website link given below. (3)


  1. Image Credit: Nansen Neuroscience Netwrok; Optinose: Novel Nasal Drug Delivery device; Web June 2013;
  2. OptiNose AS to Present Data Highlighting New Migraine Treatment at International Headache Congress;; Web June 2013;
  3. A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating The Efficacy And Safety Of A Single 20 Mg Dose Of Sumatriptan Powder Delivered Intranasally With The Bi-Directional Device In Adults With Acute Migraine With Or Without Aura; TARGET Phase III Study;; Web June 2013;


 Copyrights apply on this blog. Please read copyright permissions.